Showing results (601-610 of 3,565) with videos related to

Sort By:
Pageof 357
Antimicrobial Agents and Chemotherapy|July 1, 1974
Pleiotropic antibiotic resistance mutations associated with ribosomes and ribosomal subunits in Mycobacterium smegmatisT Yamada, K Masuda, K Shoji, et al.
Microbiology and Immunology|January 1, 1992
Genetic and biochemical analysis of ribosomal proteins of minocycline-susceptible and -resistant Mycobacterium smegmatisT Yamada, Y Mizuguchi, S Isono, et al.
Plastic and Reconstructive Surgery|November 12, 1998
Rapid three-dimensional measuring system for facial surface structureT Yamada, T Sugahara, Y Mori, et al.
Molecular Biology Reports|January 1, 1996
Epitope analysis of chromo antigen and clinical features in a subset of patients with anti-centromere antibodiesY Muro, T Yamada, T Iwai, et al.
Virology|April 14, 1997
Alternative expression of a chitosanase gene produces two different proteins in cells infected with Chlorella virus CVK2T Yamada, S Hiramatsu, P Songsri, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|January 23, 1999
[Sensitive enzyme-linked immunosorbent assay for human serum amyloid A (SAA) and application to clearance study]A Wada, T Yamada, Y Itoh, et al.
Physical Review Letters|February 21, 2006
Anisotropic water chain growth on Cu(110) observed with scanning tunneling microscopyT Yamada, S Tamamori, H Okuyama, et al.
Gynecologic and Obstetric Investigation|January 1, 1991
Retroperitoneal giant tumor formed by migrating polyembryoma with numerous embryoid bodies from an ovarian mixed germ cell tumorY Tsukahara, T Fukuta, T Yamada, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|June 1, 1990
[Measurements of prostatic acid phosphatase and prostate specific antigen by fully automated enzyme immunoassay system--its analytical and clinical evaluation]A Matui, T Yamada, O Sugita, et al.
Biomaterials, Artificial Cells, and Immobilization Biotechnology : Official Journal of the International Society for Artificial Cells and Immobilization Biotechnology|January 1, 1991
Anticoagulant therapy in a congenital antithrombin III (ATIII)-deficient patient with chronic renal failure undergoing regular hemodialysisT Matsuo, T Yamada, M Matsuo, et al.
Pageof 357